au.\*:("GROMNICA-IHLE, Erika")
Results 1 to 20 of 20
Selection :
Kodierleitfaden Rheumatologie = Coding recommendations for RheumatologyLAKOMEK, H.-J; GROMNICA-IHLE, Erika.Zeitschrift für Rheumatologie (Print). 2002, Vol 61, Num 3, issn 0340-1855, p. 336Article
Operant behavioral treatment of fibromyalgia: A controlled studyTHIEME, Kati; GROMNICA-IHLE, Erika; FLOR, Herta et al.Arthritis care and research. 2003, Vol 49, Num 3, pp 314-320, issn 0893-7524, 7 p.Article
Manifestation of rheumatoid arthritis in a patient with hereditary haemochromatosisWERNICKE, Dirk; SEIPELT, Eva; SCHMIDT, Wolfgang A et al.Rheumatology international (Berlin. Print). 2006, Vol 26, Num 10, pp 939-941, issn 0172-8172, 3 p.Article
The expression of collagenase 3 (MMP-13) mRNA in the synovial tissue is associated with histopathologic type II synovitis in rheumatoid arthritisWERNICKE, Dirk; SEYFERT, Christine; GROMNICA-IHLE, Erika et al.Autoimmunity (Print). 2006, Vol 39, Num 4, pp 307-313, issn 0891-6934, 7 p.Article
Do temporal artery duplex ultrasound findings correlate with ophthalmic complications in giant cell arteritis?SCHMIDT, Wolfgang A; KRAUSE, Andreas; SCHICKE, Bernd et al.Rheumatology (Oxford. Print). 2009, Vol 48, Num 4, pp 383-385, issn 1462-0324, 3 p.Article
Ultrasonography of Salivary Glands : A Highly Specific Imaging Procedure for Diagnosis of Sjögren's SyndromeWERNICKE, Dirk; HESS, Heidemarie; GROMNICA-IHLE, Erika et al.Journal of rheumatology. 2008, Vol 35, Num 2, pp 285-293, issn 0315-162X, 9 p.Article
Antiphospholipid syndromeGROMNICA-IHLE, Erika; SCHÖSSLER, W.International archives of allergy and immunology. 2000, Vol 123, Num 1, pp 67-76, issn 1018-2438Article
Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic lupus erythematosusZSCHIESCHANG, Petra; HIEPE, Falk; GROMNICA-IHLE, Erika et al.Pharmacogenetics (London). 2002, Vol 12, Num 7, pp 559-563, issn 0960-314X, 5 p.Article
Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany. I. Selected DMARDs and patient-related costsSCHÄDLICH, Peter K; ZEIDLER, Henning; ZINK, Angela et al.PharmacoEconomics (Auckland). 2005, Vol 23, Num 4, pp 377-393, issn 1170-7690, 17 p.Article
Hypothalamus-Pituitary-Adrenal Axis Function in Patients with Rheumatoid Arthritis Treated with Nighttime-Release PrednisoneALTEN, Rieke; DÖRING, Gisela; CUTOLO, Maurizio et al.Journal of rheumatology. 2010, Vol 37, Num 10, pp 2025-2031, issn 0315-162X, 7 p.Article
Stimulation of collagenase 3 expression in synovial fibroblasts of patients with rheumatoid arthritis by contact with a three-dimensional collagen matrix or with normal cartilage when coimplanted in NOD/SCID miceWERNICKE, Dirk; SCHULZE-WESTHOFF, Claudia; PETROW, Peter et al.Arthritis and rheumatism. 2002, Vol 46, Num 1, pp 64-74, issn 0004-3591Article
Vasculitis of the internal carotid artery in Wegener's granulomatosis : comparison of ultrasonography, angiography, and MRISCHMIDT, Wolfgang A; SEIPELT, Eva; MOLSEN, Horst P et al.Scandinavian journal of rheumatology. 2001, Vol 30, Num 1, pp 48-50, issn 0300-9742Conference Paper
Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide for rheumatoid arthritis in Germany. II. The contribution of leflunomide to efficiencySCHÄDLICH, Peter K; ZEIDLER, Henning; ZINK, Angela et al.PharmacoEconomics (Auckland). 2005, Vol 23, Num 4, pp 395-420, issn 1170-7690, 26 p.Article
HLA-DRB1 genes, rheumatoid factor, and elevated C-reactive protein : Independent risk factors of radiographic progression in early rheumatoid arthritisLISTING, Joachim; RAU, Rolf; MÜLLER, Brigitte et al.Journal of rheumatology. 2000, Vol 27, Num 9, pp 2100-2109, issn 0315-162XArticle
Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritisBUTTGEREIT, Frank; DOERING, Gisela; SCHAEFFLER, Achim et al.Annals of the rheumatic diseases. 2010, Vol 69, Num 7, pp 1275-1280, issn 0003-4967, 6 p.Article
Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system. CommentaryILLEI, Gabor G; ALEXANDER, Tobias; BURMESTER, Gerd-Rüdiger et al.Blood. 2009, Vol 113, Num 1, issn 0006-4971, 2-3, 214-223 [12 p.]Article
Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylosing spondylitisBARALIAKOS, Xenofon; LISTING, Joachim; SORENSEN, Helmut et al.Journal of rheumatology. 2007, Vol 34, Num 3, pp 510-515, issn 0315-162X, 6 p.Article
Infections in patients with rheumatoid arthritis treated with biologic agentsLISTING, Joachim; STRANGFELD, Anja; SCHNEIDER, Matthias et al.Arthritis and rheumatism. 2005, Vol 52, Num 11, pp 3403-3412, issn 0004-3591, 10 p.Article
Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitisZINK, Angela; THIELE, Katja; SCHNEIDER, Matthias et al.Journal of rheumatology. 2006, Vol 33, Num 1, pp 86-90, issn 0315-162X, 5 p.Article
Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patientsCERVERA, Ricard; PIETTE, Jean-Charles; GALEAZZI, Mauro et al.Arthritis and rheumatism. 2002, Vol 46, Num 4, pp 1019-1027, issn 0004-3591Article